Navigation Links
How do plants fight disease?
Date:3/28/2011

RIVERSIDE, Calif. How exactly bacterial pathogens cause diseases in plants remains a mystery and continues to frustrate scientists working to solve this problem. Now Wenbo Ma, a young plant pathologist at the University of California, Riverside, has performed research on the soybean plant in the lab that makes major inroads into our understanding of plant-pathogen interactions, a rapidly developing area among the plant sciences.

Her breakthrough research can help scientists come up with effective strategies to treat crops that have succumbed to disease or, when used as a preventative measure, to greatly reduce their susceptibility to disease.

In a paper published in the March issue of the journal Cell Host & Microbe, Ma, an assistant professor of plant pathology and microbiology, and her colleagues show that the bacterial pathogens target isoflavones, a group of compounds in plant cells that defend the plant from bacterial infection, resulting in a reduction in isoflavone production.

An arms race

First, the pathogens inject virulence bacterial proteins, called HopZ1, through needle-like conduits into the plant cells. These proteins then largely reduce the production of the isoflavones and promote disease development. However, by sensing the presence of HopZ1, the plants mount a robust resistance against the pathogen, including the production of a very high amount of isoflavones. At this point, the pathogen must come up with new strategies by either changing the kind of proteins it injects into the plant, not injecting any proteins at all, or injecting virulence proteins in a way that helps them escape detection by the plant. In this way, the virulence bacterial proteins and the plant host engage in an endless "arms race."

"One question we are still trying to answer is how at the molecular level the bacterial virulence proteins promote disease," Ma said. "Some scientists have shown that these proteins block signaling transduction pathways in the plant, which eventually weakens plant immunity. We are introducing a fresh perspective on this topic, namely, that the pathogens evolved strategies to directly attack the production of plant antimicrobial compounds, such as isoflavones, thus compromising the plant's defense mechanism."

Closing the circle

According to Ma, her results can be extrapolated to understand how plants defend themselves when attacked by pathogens. She is pleased to be resuming research first studied by UC Riverside's Noel Keen, the late plant scientist and a pioneer in molecular plant pathology, who did fundamental groundbreaking work on understanding how isoflavones and isoflavone-derived compounds play a role in defending plants against microbial infection.

"This was an important topic of study about 30 years ago, but then the topic was dropped by researchers and it lost momentum," Ma said. "My lab is now revisiting the problem. Of course, we still have many questions to answer. We need to fully understand how isoflavones function to protect plants so that we can design specific strategies aimed at better protecting the plant."

Looking forward

Ma's lab is also interested in understanding what makes pathogens what they are. Why is it that among ecologically similar bacteria, some cause disease while others do not? Her lab is also studying how plants evolve mechanisms to protect themselves from infection, how pathogens subvert this defense and become virulent again.

"Pathogens get wise to the disease-fighting strategies we use in agriculture," Ma said. "This is evolution at work. But with fundamental knowledge on how pathogens cause disease we can develop sustainable and applicable strategies to combat disease."


'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Related biology news :

1. UC Riverside geneticists to study how plants adapt to a changing environment
2. Nanomodified surfaces seal leg implants against infection
3. Ecologists use 70-year-old pressed plants to chart citys vanishing native flora
4. Plasticity of plants helps them adapt to climate change
5. MU researcher leads new $6.6 million study that could lead to better corn plants
6. Study shows how plants sort and eliminate genes over millennia
7. Evolution drives many plants and animals to be bigger, faster
8. New growth inhibitors more effective in plants, less toxic to people
9. Flood-tolerant rice plants can also survive drought, say UC Riverside scientists
10. Parasitic protozoons survive waste water and drinking water treatment plants in Galicia
11. Plants that can move inspire new adaptive structures
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How do plants fight disease?
(Date:2/3/2016)... , February 4, 2016 --> ... to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of ... amounted to SEK 517.6 M (loss: 30.0). Earnings per share ... activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 /PRNewswire/ ... facilities are primarily focused on medical screening ... measure point-of-care parameters. Wearable devices that facilitate ... user,s freedom of movement are being bolstered ... for human biomedical signal acquisition coupled with ...
(Date:2/2/2016)... 2016   Parabon NanoLabs (Parabon) announced ... Research Office and the Defense Forensics and Biometrics ... the company,s Snapshot Kinship Inference software ... generally, defense-related DNA forensics.  Although Snapshot is best ... and ancestry from DNA evidence), it also has ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today provided an update on the Company,s cases ... Texas and announcing that those ... Re-examination ("IPR") proceedings that VTech and Uniden filed ... on only certain claims of two of the patents ...
(Date:2/3/2016)... Feb. 3, 2016   ViaCyte, Inc ., ... first pluripotent stem cell-derived islet replacement therapy for ... development, today announced that ViaCyte and Janssen Biotech, ... Johnson & Johnson, have agreed to consolidate the ... The agreement provides ViaCyte with an exclusive license ...
(Date:2/3/2016)... , Feb. 3, 2016 New ... more than $1 million for researchers in ... on health-related research that demonstrates exciting potential.   ... of funding for the New Jersey Health Foundation Research ... members at these educational institutions— Princeton University, Rutgers ...
(Date:2/3/2016)... -- Silk Therapeutics, Inc., today announced the closing of a $6 ... a total of $10.25 million in Series A funding based ... round was led by existing investor The Kraft Group of ... investors Lear Corporation and Highland Consumer Partners, as well as ... Richard Sackler , MD, with Summer Road, LLC; Erin ...
Breaking Biology Technology: